Recall Alert: Blood Pressure Drug Ziac Recalled for Possible Cross-Contamination (2026)

A serious situation has emerged: a common blood pressure medication has been recalled due to potential contamination. This recall highlights the importance of medication safety and the rigorous standards the FDA upholds.

The Food and Drug Administration (FDA) has issued a recall for a popular treatment for high blood pressure. The medication, a combination of bisoprolol fumarate and hydrochlorothiazide, is sold under the brand name Ziac. But here's where it gets controversial: the recall stems from a potential cross-contamination issue.

According to reports from USA Today, the medication may have been contaminated with traces of ezetimibe, a cholesterol drug, manufactured by the same company. This is a significant concern because it means patients could have been unknowingly exposed to a drug they weren't prescribed, potentially leading to unforeseen side effects or interactions.

The recall affects specific dosages of the medication, ranging from 2.5 mg to 6.25 mg. The drugmaker, Madhya Pradesh in India, produced the affected tablets for Glenmark Pharmaceuticals. The Hill reported that over 11,100 bottles have been recalled.

Here's a breakdown of the specific products affected:

  • 30-tablet bottles, NDC-68462-878-30. Lot 17232401, expiration 11/2025.
  • 100-tablet bottles, NDC-68462-878-01. Lot 17232401, expiration 11/2025.
  • 500-tablet bottles, NDC-68462-878-05. Lots 17232401, exp. 11/2025 and 17240974, expiration 05/2026.

But what does this recall mean for patients? The FDA has classified this recall as Class III, indicating that exposure to the contaminated product is unlikely to cause serious adverse health consequences. However, any medication error warrants attention and monitoring.

So, what is this medication used for? Bisoprolol fumarate and hydrochlorothiazide are prescribed in combination to treat high blood pressure. Bisoprolol fumarate is a heart beta-blocker, helping the heart beat normally. Hydrochlorothiazide is a diuretic that increases urination, helping to remove excess sodium and water from the body. Together, these medications help relax blood vessels, lowering blood pressure and reducing the risk of heart attacks and strokes. And this is the part most people miss: ensuring the medication is taken correctly is as crucial as the medication itself.

This recall is a reminder of the importance of vigilance in the pharmaceutical industry. It's essential for patients to stay informed about their medications and to report any concerns to their healthcare providers. What do you think about the implications of this recall? Do you think the FDA's classification of the recall as Class III is appropriate? Share your thoughts in the comments below!

Latest Recalls:

  • Recall alert: 72K Ram trucks recalled over problem with instrument panels
  • Recall alert: 109K Ford Escapes recalled over liftgate hinge issue
  • Recall alert: Mondelēz Global recalls RITZ Peanut Butter Cracker Sandwiches
  • Recall alert: 17K children’s sport tumblers recalled
  • Recall alert: 10K writing tablet toys recalled

©2025 Cox Media Group

Recall Alert: Blood Pressure Drug Ziac Recalled for Possible Cross-Contamination (2026)

References

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Patricia Veum II

Last Updated:

Views: 5973

Rating: 4.3 / 5 (64 voted)

Reviews: 87% of readers found this page helpful

Author information

Name: Patricia Veum II

Birthday: 1994-12-16

Address: 2064 Little Summit, Goldieton, MS 97651-0862

Phone: +6873952696715

Job: Principal Officer

Hobby: Rafting, Cabaret, Candle making, Jigsaw puzzles, Inline skating, Magic, Graffiti

Introduction: My name is Patricia Veum II, I am a vast, combative, smiling, famous, inexpensive, zealous, sparkling person who loves writing and wants to share my knowledge and understanding with you.